查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1321755

3D生物打印的全球市场

3D Bioprinting
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球 3D 生物打印市场将达到 79 亿美元

在COVID-19之后的商业环境发生变化的情况下，全球3D生物打印市场预计2022年为25亿美元，预计到2030年将达到79亿美元，2022年至2030年将增长15.3%。预计增长为年复合成长率为本报告分析的喷墨细分市场之一预计复合年增长率为 16.2%，到分析期结束时将达到 33 亿美元。鑑于疫情后的持续復苏，磁悬浮领域的增长已将未来八年的年复合成长率修正为16.9%。

美国市场预计将增长 7.491 亿美元，中国复合年增长率为 14.5%

到 2022 年，美国 3D 生物打印市场预计将达到 7.491 亿美元。中国作为全球第二大经济体，预计在2022年至2030年的分析期间将以14.5%的复合年增长率增长，预计2030年市场规模将达到13亿美元。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 13.1% 和 12.3%。在欧洲，德国预计将以 10% 左右的年复合成长率增长。

受访企业示例

  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical KK
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D SL
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 大公司
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 我们
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第4章竞争

简介目录
Product Code: MCP21002

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global 3D Bioprinting Market to Reach $7.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for 3D Bioprinting estimated at US$2.5 Billion in the year 2022, is projected to reach a revised size of US$7.9 Billion by 2030, growing at aCAGR of 15.3% over the period 2022-2030. Inkjet-based, one of the segments analyzed in the report, is projected to record 16.2% CAGR and reach US$3.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Magnetic Levitation segment is readjusted to a revised 16.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $749.1 Million, While China is Forecast to Grow at 14.5% CAGR

The 3D Bioprinting market in the U.S. is estimated at US$749.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 14.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.1% and 12.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.

Select Competitors (Total 34 Featured) -

  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D S.L.
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • 3D Bioprinting - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Living Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Living Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracellular Matrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Extracellular Matrices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Research Organizations & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Research Organizations & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World 3D Bioprinting Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Inkjet-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Inkjet-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Magnetic Levitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Magnetic Levitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Laser-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World 8-Year Perspective for Laser-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Other Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • JAPAN
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Japan 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Japan 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • CHINA
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: China 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: China 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • EUROPE
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 55: Europe 8-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • FRANCE
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: France 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • GERMANY
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Germany 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Italy 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • UNITED KINGDOM
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: UK 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • ASIA-PACIFIC
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2023 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Rest of World 8-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World 8-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2023 & 2030

IV. COMPETITION